Skip to main content

School of Pharmaceutical Sciences, Universiti Sains Malaysia

  • Qualification

    PhD (Pharmaceutics) (UCL), MSc (Pharmaceutical Technology) (USM), BPharm (Hons) (USM)

  • Senior Lecturer

    Discipline of Pharmaceutical Technology

  • Room

    J06 Room 116

  • Contact

    +604-6577888 Ext. 6656

  • Email

    noratiqah@usm.my

Author ID

Noratiqah Mohtar, Dr

Dr. Noratiqah Mohtar is a senior lecturer at the School of Pharmaceutical Sciences, USM. Having attained her PhD from University College London, UK, in 2018, she subsequently joined USM in the same year.
In her current capacity as a senior lecturer, Dr. Mohtar actively engages in teaching, research, and postgraduate supervision within the field of Pharmaceutical Technology. Her research interest revolves around drug delivery and formulation, with a specific focus on developing inhalable drug delivery systems for the treatment of lung-related diseases. Additionally, she is exploring the potential of phytochemicals to enhance the efficacy of anticancer drugs in treating lung cancer.
Dr. Mohtar's dedication to advancing pharmaceutical research can be seen through her publication in reputable journals, covering topics ranging from nanomedicine to phytochemical formulations and drug delivery. She currently holds the position of Honorary Secretary in the Malaysian Society of Pharmaceutical Technology.

Research Interest: 

  1. Nanoformulation and solubility improvement of therapeutic compounds
  2. Pulmonary drug delivery
  3. Oral drug delivery
  4. Anticancer activities of phytochemicals

Ongoing Research

  1. Formulation of therapeutic molecules into an inhalable dosage form for lung-related diseases.
  2. Development of water-soluble complex to facilitate oral delivery of drug.
  3. Exploring the role of phytochemicals in enhancing the cytotoxic effects of anticancer agents.
  1. Development and characterisation of nanoformulation for oral and pulmonary drug delivery
  1. Megantara, S., Rusdin, A., Budiman, A., Shamsuddin, S., Mohtar, N., Muchtaridi, M. (2024) Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy. International Journal of Nanomedicine, 2024(19): 2889-2915.
  2. Supramaniam, K., Gazzali, A.M., Noor, N.M., Abdul-Aziz, A., Nimmano, N., Mohtar, N. (2024) A review on supporting roles of phytochemicals and advances in their nanoformulations for lung diseases. Malaysian Journal of Medicine and Health Sciences, 20(SUPP1): 198-211.
  3. Alasas, A.B., Mohtar, N., Gazzali, A.M. (2024) Preparation, characterization and in vitro drug release evaluation of chitosan nanoparticles for atovaquone. Malaysian Journal of Medicine and Health Sciences, 20(SUPP1): 75-84.
  4. Rahiman, S.S.F., Al-Amin, M., Mohtar, N., Zakaria, I.I., Kahar, U.M., Khairuddean, M., Salhimi, S.M. (2024) Potential inhibitors isolated from Curcuma aeruginosa against dengue virus type 2 (DENV-2) NS2B-NS3 protease activity. Journal of Biologically Active Products from Nature, 14(1): 64-79.
  5. Ramachandran, S., Prakash, P., Mohtar, N., Kumar, K.S., Parumasivam, T. (2023) Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs. Pharmaceutical Development and Technology, 28(10), 978-991.
  6. Ballouze, R., Muhamad Salhimi, S., Mohtar, N., Fazalul Rahiman, S.S. (2023) Dynorphin 1-17 biotransformation peptides: properties, challenges and solutions for future therapeutics development. Future Medicinal Chemistry, 15(9), 791-808.
  7. Al-Thiabat, M.G., Gazzali, A.M., Mohtar, N., Murugaiyah, V., Kamarulzaman, E.E., Yap, B.K., Rahman, N.A., Othman, R., Wahab, H.A. (2021) Conjugated β-cyclodextrin enhances the affinity of folic acid towards FRα: molecular dynamics study. Molecules, 26 (17), 5304.
  8. Abdulbaqi, I.M., Assi, R.A., Yaghmur, A., Darwis, Y., Mohtar, N., Parumasivam, T., Saqallah, F.G., Wahab, H.A. (2021) Pulmonary delivery of anticancer drugs via lipid-based nanocarriers for the treatment of lung cancer: An update. Pharmaceuticals, 14(8), 725.
  9. Mohtar, N., Hanafiah, N.H.M., Ng, S.Y., Gazzali, A.M., Parumasivam, T. (2021) Proof of Concept: The Effectiveness of Disinfectant Tunnel as Potential Measure against COVID-19. Sains Malaysiana, 50 (7), 2135-2140.
  10. Mohtar, N., Parumasivam, T., Gazzali, A.M., Tan, C.S., Tan, M.L., Othman, R., Fazalul Rahiman, S.S., Wahab, H.A. (2021) Advanced nanoparticle-based drug delivery systems and their cellular evaluation for non-small cell lung cancer treatment. Cancers, 13, 3539.
  11. Razak, S.A.A., Gazzali, A.M., Fisol, F.A., Abdulbaqi, I.M., Parumasivam, T., Mohtar, N., Wahab, H.A. (2021) Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: An overview. Cancers, 13, 400.
  12. Ruslan, N.S., Mohtar, N., Rahiman, S.S.F., Gazzali, A.M. (2020) The influence of preparation factors on physical characteristics of chitosan nanoparticles. Journal of Physical Science, 31(3), 47-60.
  13. Mohtar, N., Taylor, K. M. G., Sheikh, K., Somavarapu, S. (2017) Design and development of dry powder sulfobutylether-β-cyclodextrin complex for pulmonary delivery of fisetin. European Journal of Pharmaceutics and Biopharmaceutics, 113, 1-10.
  14. Mohtar, N., Khan, N. A. K., Darwis, Y. (2015) Solid lipid nanoparticles of atovaquone based on 2˄4 full-factorial design. Iranian Journal of Pharmaceutical Research, 14(4), 989-1000.
  15. Mohtar, N., Khan, N. A. K., Darwis, Y. (2015) A simple HPLC-UV method for quantification of atovaquone in rabbit plasma. Journal- Indian Chemical Society, 92, 1491-1497.
  16. Khan, A. A., Mudassir, J., Mohtar, N., Darwis, Y. (2013) Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. International Journal of Nanomedicine, 8, 2733-2744.
  1. FAR122 Dosage Form I
  2. FAR222 Dosage Form II
  3. FAR224 Drug Delivery and Targeting
  4. HFF225 Philosophy and Current Issue
  1. Pyrogen testing for pharmaceutical products